The pharma giant plans to increase manufacturing as part of a US$23 billion effort to reduce US government pressure.

Sales will be about $65 billion in the fiscal fourth quarter, which runs through January, Nvidia said in a statement ...

Discover why Pfizer stock may be set for a bull run by 2026 with key wins, strong Q3 earnings, and growth drivers.

The partnership will expedite the availability of Freenome's tests in markets outside the U.S, according to the company.

Real estate giant Greystar has reached a $7 million settlement with nine states over its use of rent-setting algorithms that officials say drive up housing costs. The proposed settlement was ...

Amid the pharma industry's breakneck onshoring push this past year, North Carolina has been a major beneficiary as investment announcements rolled in from the likes of ...

The Swiss pharmaceutical firm is the third company this week to announce a major investment in North Carolina, part of a wave ...

Merck & Co, known as MSD outside of the USA and Canada, today announced that the European Commission (EC) has approved a new ...

In this week’s edition of InnovationRx, we look at the biotech deal frenzy, Recursion’s incoming CEO, the infant formula ...

Choose Triangle Business Journal as a preferred news source to see more of our reporting on Google.

Pfizer (PFE) stock is in focus as the firm joins Tris Pharma to settle a lawsuit over supplying an adulterated ADHD drug to ...

The pharma giant looks likely to conduct a stock split in the (relatively) near future. 10 stocks we like better than Eli ...